𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering

✍ Scribed by Ramakrishnaiah Siddappa; Ruud Licht; Clemens van Blitterswijk; Jan de Boer


Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
563 KB
Volume
25
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The use of multipotent human mesenchymal stem cells (hMSCs) for tissue engineering has been a subject of extensive research. The donor variation in growth, differentiation and in vivo bone forming ability of hMSCs is a bottleneck for standardization of therapeutic protocols. In this study, we isolated and characterized hMSCs from 19 independent donors, aged between 27 and 85 years, and investigated the extent of heterogeneity of the cells and the extent to which hMSCs can be expanded without loosing multipotency. Dexamethasone‐induced ALP expression varied between 1.2‐ and 3.7‐fold, but no correlation was found with age, gender, or source of isolation. The cells from donors with a higher percentage of ALP‐positive cells in control and dexamethasone‐induced groups showed more calcium deposition than cells with lower percentage of ALP positive cells. Despite the variability in osteogenic gene expression among the donors tested, ALP, Collagen type 1, osteocalcin, and S100A4 showed similar trends during the course of osteogenic differentiation. In vitro expansion studies showed that hMSCs can be effectively expanded up to four passages (approximately 10–12 population doublings from a P0 culture) while retaining their multipotency. Our in vivo studies suggest a correlation between in vitro ALP expression and in vivo bone formation. In conclusion, irrespective of age, gender, and source of isolation, cells from all donors showed osteogenic potential. The variability in ALP expression appears to be a result of sampling method and cellular heterogeneity among the donor population. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:1029–1041, 2007


📜 SIMILAR VOLUMES


Evaluation of human mesenchymal stem cel
✍ Caixia Xu; Yingjun Wang; Xinbing Yu; Xiaofeng Chen; Xiangjun Li; Xuhui Yang; Shu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

## Abstract The aim of this study was to examine __in vitro__ the response of human mesenchymal stem cells (hMSCs) on the novel biomimetic bioglass‐collagen‐hyaluronic acid‐phosphatidylserine (BG‐COL‐HYA‐PS) composite scaffold for potential use in bone tissue engineering. The initial attachment, th

Importance of serum source for the in vi
✍ Shivali Duggal; Jan E. Brinchmann 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

## Abstract Human mesenchymal stem cells (hMSCs) may be used for therapeutic applications. Culture conditions such as the serum source may impact on cell quality and the onset of replicative senescence. We have examined the effect of culturing hMSCs in autologous serum (AS) versus fetal bovine seru

Mechano-functional assessment of human m
✍ Kathryn S. Stok; Gina Lisignoli; Sandra Cristino; Andrea Facchini; Ralph Müller 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 1 views

## Abstract Human mesenchymal stem cells (hMSCs) are an alternative cell source in bioconstruct production for cartilage regeneration, and hyaluronic acid (HA) is a widely‐used bioabsorbable scaffold material used for cartilage regeneration. In this work, the aims were to evaluate the mechanical co